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Figure S1. Photoreceptor marker expression in the human peripheral and central retina (related to 
Figure 1). 
(A) qRT PCR analysis of pan photoreceptor markers, cone-rod homeobox gene (CRX) and recoverin (RCVRN) 
in foetal (9pcw-20pcw) and adult retinal samples (n = 1 per timepoint). (B) RECOVERIN and CRX protein 
expression in the peripheral and central region of the developing retina (9pcw-19pcw). (C) Differences in retinal 
maturity are highlighted by KI67 immunostaining, present in the peripheral retina but absent in the central 
retina. (D) Rod marker, NR2E3, expression in the peripheral and central 19pcw retina. Wholemount image scale 
bar: 100µm; tissue section scale bar: 50µm. RPE, retinal pigment epithelium; ONBL, outer neuroblastic layer; 
INBL, inner neuroblastic layer; ONL, outer nuclear layer; OPL, outer plexiform layer; INL, inner nuclear layer; 





















































Figure S2. AAV2/9.pR2.1:GFP reporter expression in human foetal retinal explant culture system 
(related to Figure 2). 
(A) Brightfield wholemount images showing 13pcw retinal explant at 3 and 5 days in vitro (DIV) using a free 
floating culture method. (B) Dissociation and flow cytometry analysis of the explant on 7 DIV shows a high 
level of cell viability. (C) Representative images of 12pcw (+7DIV) retinal explant showing preserved cone 
photoreceptor marker staining (S-OPSIN, L/M-OPSIN, RXRG) and retinal integrity. Wholemount images 
showing pR2.1:GFP+ signal within cultured 12pcw (D) and 19pcw (E) retinal explants. (F) Sections of a 12pcw 
(+7DIV) retinal explant showing the absence of KI67 expression within pR2.1:GFP+ cells. Insert shows KI67 
positive control for antibody.  Scale bar for wholemount images of foetal retinal explants: 1mm; tissue section 
scale bar: 50µm. ONBL, outer neuroblastic layer; INBL, inner neuroblastic layer. (G) Counting of the marker + 
and GFP+ cells from immunofluorescence data in Figure 1L-O. Three sections of a 12pcw retinal explant 
transduced with the pR2.1:GFP reporter were counted for each immunostaining experiment (1 field of view per 
section where GFP+ cells and marker + cells could be seen). 0% of GFP+ cells co-labelled with NR2E3 (55 
GFP+  cells counted in total), 0% of cells co-labelled with S-OPSIN (44 GFP+ cells counted in total), 100% of 
cells co-labelled with RXRG (84 GFP+/RXRG+ cells; 84 GFP+ cells counted in total) and 54.7% of cell co-















































Figure S3. Efficiency of AAV2/9.pR2.1:GFP reporter and pR.2.1:GFP+ cell isolation via FACS (related to 
Figure 1 and 2). 
(A) L/M-OPSIN immunostaining on dissociated pR2.1:GFP+ 14pcw and 18pcw (+7DIV) retinal explants show 
GFP+ cells co-label with L/M-OPSIN expression (white arrows). (B) Counting of these cells reveals the number 
of L/M-OPSIN+ cells and pR2.1:GFP+ cells in  each sample. In test samples, reporter labelling efficiencies of 
14% and 4% were achieved in 14pcw (30 GFP+/214 L/M-OPSIN+ cells) and 18pcw (9 GFP+/230 L/M-
OPSIN+ cells) retinae, respectively. (C) Representative FACS traces of foetal pR2.1:GFP+ retinal explants 























































Figure S4. Photoreceptor gene expression profile across single AAV2/9 pR2.1:GFP labelled cells (related 
to Figure 3). 
Gene expression (log2 normalised counts) profiles of pan photoreceptor genes (RCVRN and CRX; A), cone 
photoreceptor genes (RXRG and THRB; B), S-cone (OPN1SW) and rod photoreceptor genes (NRL and NR2E3; 
C) across individual human foetal 15pcw pR2.1:GFP+ cells correlated to PC1. Each dot represents a cell and the 
cell position across PC1 (x-axis) is determined by its differential gene expression, which is indicated by colour 



























Figure S5. Photoreceptor differentiation from iPSCs using 3D retinal organoid culture system (related to 
Figure 4) 
(A i-iv) Protein expression of CRX and RECOVERIN was detected within iPSC-derived optic vesicle structures 
from week 6 through to week 22 of differentiation. (B) qRT PCR analysis of cone photoreceptor marker 
transcripts during retinal differentiation culture; n = 3 per timepoint. Error bars represent ± SD. Tissue section 









































Figure S6. SSEA-1 expression in the human foetal retina (related to Figure 5) 
Flow cytometry traces of pR2.1:GFP+ cells vs SSEA-1+ cells in the 12pcw and 17pcw foetal retina. Cells co-
labelling for SSEA-1 and pR2.1:GFP+ cells were not detected at either timepoint in the foetal retinal samples, 
suggesting SSEA-1 is not expressed by pR2.1:GFP+ cone cells. In the 17pcw sample, SSEA-1 labelled 32.4% 










































Figure S7. Cone differentiation and cone CD marker FAC-sorting from PSCs using retinal differentiation 
protocols (related to Figure 6) 
(A-B) Histological sections of iPSC-derived optic vesicles generated using (A) the adapted Meyer et al., 2009 
protocol (protocol 1) used for RNA seq analysis (refer to Figure 4) and (B) ESC-derived optic vesicles 
generated using the new protocol developed by Gonzalez-Cordero et al., 2017 (protocol 2; H9). 
Immunohistological analysis with CONE ARRESTIN/CRX antibodies detected CONE ARRESTIN by week 
17.5 of differentiation within the ESC-derived vesicles (B). Scalebar of retinal tissue section: 50µm.  
(C) Representative flow cytometry traces showing the cell populations obtained when applying the cone CD 
marker combination (SSEA-1/CD133/CD26/CD147) onto (C i) the human foetal retina (example shows 17pcw 
foetal retina),  (C ii) Week 20 iPSC-derived retinal differentiation cultures generated using protocol 1 (adapted 
Meyer et al., 2009 protocol),  (C iii) Week 17-18 ESC (mShef10; ESC 1)-derived retinal differentiation cultures 
generated using protocol 2 (developed by Gonzalez-Cordero et al., 2017), (C iv) Week 17-18 ESC (H9; ESC 2)-
derived retinal differentiation cultures generated using protocol 2. The foetal retina flow cytometry traces were 
used as a baseline reference for cone cell enrichment (C i). Retinal differentiation of ESC lines with protocol 2 
(C iii and C iv) showed SSEA1-CD133+CD26+CD147+ cell populations most similar to the foetal traces. Cell 












SUPPLEMENTAL EXPERIMENTAL PROCEDURES 
PSC maintenance and retinal differentiation 
iPSCs were cultured on irradiated mouse embryonic fibroblast layer (GlobalStem) in knockout serum 
replacement medium (KSR; DMEM/F12 1:1 (Gibo), 20% Knockout Serum Replacement (KOSR; Life 
Technologies), 1% MEM non-essential amino acids (Life Technologies), 2mM L-glutamine (Life 
Technologies), 0.007% 2-mercaptoethanol (Life Technologies)) with 4ng/ml fibroblastic growth factor (FGF; 
Peprotech). H9 ESCs (Wicell) were cultured in feeder free conditions in E8 (Thermo Fisher) and geltrex coated 
6 well plates. mShef10 ESCs (Centre for Stem Cell Biology, The University of Sheffield) were cultured in 
Nutristem (Geneflow) on Laminin-521 (BioLamina) coated 6 well plates. The retinal differentiation protocol for 
transcriptome profiling of iPSC-derived cones was based on Meyer et al., 2009 (Protocol 1). iPSC colonies were 
enzymatically lifted using 0.1% w/v dispase-DMEM/F12 (Life Technologies) on Day 0 and transfer into T25 
flasks containing KSR medium without FGF to induce the formation of embryoid bodies (EBs). Medium was 
changed daily before substituting into neural induction medium (NIM) containing DMEM/F12 1:1 (Gibco), 1% 
MEM non-essential amino acids (Life Technologies), 1% N2 supplement (Gibco), 0.1% heparin (Sigma) on 
Day 4. To promote neural rosette formation, EBs were transferred onto 30% v/v laminin-DMEM/F12 (Sigma) 
coated plates in NIM on Day 6; neural rosettes appeared by differentiation day 8/9. Cultures were then fed every 
2 days with NIM until Day 16, where the media was substituted for retinal differentiation media (RDM; 70% 
DMEM (Gibco), 30% F12 (Gibco) and 2% B27 supplement (Gibco)). Optic vesicle structure was visible from 
Day 18-20 onwards and media was changed every 2-3 days. 10% FBS (Gibco) was added to cultures at week 14 
for late stage cultures. For CD marker FAC-sorting experiments, iPSCs were differentiated using protocol 1 
(based on Meyer et al., 2009) and mShef10 and H9 lines were differentiated using the protocol as described in 
(Gonzalez-Cordero et al., 2017).  
 
Human foetal retinal explant culture 
Foetal retinae were isolated under sterile conditions in DMEM to remove surrounding ocular tissue using 
stainless steel 8mm blade curved micro scissors and 0.1mm straight forceps (World Precision Instruments). 
Intact foetal retina were cultured free floating in 12 or 24 well plates with retinal differentiation media (RDM) 
containing DMEM-F12 (Gibco), 1% Glutamax (Gibco), 1% N2 and 1% B27 neural supplements (Gibco), 10% 
FBS (Invitrogen) and 1.5% penicillin/streptomycin (Invitrogen). Cell culture media was changed every 2 days. 
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AAV2/9.pR2.1:GFP production and application 
293T cells were cultured in D10 medium containing DMEM+Glutamax (Life Technologies), 10% FBS (Life 
Technologies) and 1% pencillin/streptomycin (Life Technologies) in 150cm plates (20 plates required for one 
batch of virus) and grown to 80% confluency. 100µg pd10/pR2.1.L/Mopsin-eGFP construct, 30µg pHGT1 
helper vector, 100µg AAV2/9 caspid were added to 52.5ml DMEM and 1.2ml PEI polyethylenimine (PEI) prior 
to addition onto the 293T cells which facilitated transfection, before harvesting the cells after 72 hours using a 
cell scraper and collecting in TD buffer and performing four freeze (-80°C), thaw (37°C), vortex cycles for viral 
release. The pR2.1.L/M-opsin promoter was originally generated by the Jeremy Nathans group (Wang et al., 
1992). Virus lysate underwent benzonase treatment (50 units; Sigma) and was prepared for purification through 
multiple centrifugation steps and sequential filtering with 5µm, 0.45µm and 0.22µm PES membranes. Virus was 
purified via ion exchange fast protein liquid chromatography using AKTA Prime (GE Healthcare) and anionic 
sephacryl S300 and POROS 50HQ columns prior to elution with an increasing salt gradient. The elution was 
concentrated using a Vivaspin 4 column (Sartorius) to a final volume ranging between 250-400µl. Viral 
genomic titer was determined through qRT PCR and the virus titer used in this study ranged from 1.48x1013-
1.01x1014. Virus was added to foetal retinal explant and iPSC-derived retinal differentiation cultures at a MOI of 
40,000-45,000. 
 
Fluorescence-activated cell sorting (FACS) of human retinal cells 
Human foetal and PSC-derived retinal tissue were enzymatically dissociated into single cells using the papain 
dissociation system (Worthington Biochemical, Lorne Laboratories, UK) according to manufacturer’s protocol. 
All samples were passed through 70µm cell strainer prior to FACS. For FAC-sorting of pR2.1.GFP+ and GFP- 
retinal material, cells were resuspended in blocking solution (BS; 1% (w/v) BSA/PBS) with the addition of 
DAPI (2µl; Sigma) before sorting to allow the determination of live cell population. For cone CD marker 
sorting, cells were counted using a haemocytometer and resuspended in BS at a concentration of 1x10⁶ cells per 
100ul. After incubating cell for 1 hour on ice, conjugated antibodies (APC-conjugated SSEA-1, clone REA321, 
Miltenyi Biotec, Cat no. 130-104-936; PE- conjugated CD26, clone M-A261, BD Biosciences, Cat no. 555437; 
PE- Vio770-conjugated CD133, clone 293C3, Miltenyi Biotec, Cat no. 130-104-117; PerCP-Cy5.5-conjugated 
CD147, clone HIM6, BD Biosciences, Cat no. 562554) or isotype controls were added to cells using the 
manufacturer’s recommendations and incubated for a further hour on ice in the dark. Cells were washed in PBS 
and resuspended in BS for sorting. The BD FACSARIA III was used to isolate cells which were collected into 
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50% (v/v) FBS/DMEM media. FITC-A vs PerCP-Cy5-5A channels were used to detect GFP+ signal, whereas 
the according channels matching the fluorophores of the conjugated CD marker antibodies were used to detect 
positive signal. Isotype and unstained controls were used to set gates and apply necessary compensation. Post-
sorting, cells were centrifuged at 300 x g for 15 minutes at 4°C; cell pellets for RNA extraction were 
immediately snap frozen on dry ice, whereas cells for immunocytochemistry were plated out on to pre-coated 
poly-L-lysine (Sigma) and laminin (1:30; Sigma) chamber slides. For FACS analysis of foetal and ESC-derived 
retinal samples, 4 independent samples were analysed for each CD marker combination and at least 50 cells 
were counted for each FAC-sorted cell population. FlowJo flow cytometry software was used for FACS trace 
visualisation and analysis. 
 
Immunocytochemistry on dissociated retinal cells 
Dissociated retinal cells on chamber slides were fixed in 4% (w/v) PFA/PBS for 5 minutes at 37°C prior to a 
further 15 minutes incubation in 2% (w/v) PFA/ 30% (w/v) sucrose/PBS at room temperature (RT). Cells were 
washed three times in PBS and incubated for 1 hour at RT in BS (10% (v/v) foetal bovine serum (FBS)/PBS 
(Gibo), 1% (w/v) bovine serum albumin/PBS) with 0.1% (v/v) Triton X-100. Primary antibodies (L/M-opsin, 
Millipore, Cat no. AB5405, 1:400, CRX, Abnova, H00001406-M02,  1:800; Cone arrestin, NovusBio, NBP1-
19629, 1:100) were added on to cells and incubated for 1 hour at RT. Cells were washed with three times in PBS 
and incubated for a further hour with secondary antibodies (Alexa Fluor 594 Goat anti-rabbit IgG (Cat no. 
A11032) or Alexa Fluro 488 Goat anti-mouse IgG (Cat no. A1080), Invitrogen, 1:800). The same procedure was 
conducted for CD marker immunocytochemistry (L/M-opsin, Millipore, Cat no. AB5405, 1:400, Cone arrestin, 
NovusBio, NBP1-19629, 1:100, PE- conjugated CD26, 1:500, BD Biosciences, Cat no. 555437; PE- Vio770-
conjugated CD133, 1:500, Miltenyi Biotec, Cat no. 130-104-117; PerCP-Cy5.5-conjugated CD147, clone 1:500, 
BD Biosciences, Cat no. 562554) on dissociated cells, with the removal of Triton X-100 from BS. DAPI 
incubation and mounting procedure was performed as described in histology and immunohistochemistry section.  
 
Human BD lyoplate screening panel protocol  
Retinal samples previously transfected with AAV2/9.pR2.1:GFP reporter were dissociated using the papain 
method as described in the FACS methods section and the protocol for the human BD LyoplateTM Screening 
Panels was followed accordingly to manufacturer’s instructions. Briefly, cells were resuspended in BD 
Pharmingen Stain Buffer with 5mM EDTA to a cell concentration of 25k-1x106 cells/100µl and aliquoted into 
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3x BD Falcon™ round bottom 96 well plates (100µl per well). Primary antibodies of the BD LyoplateTM 
Screening Panels were reconstituted in 1x PBS (110µl per well) and 20µl of each antibody was then added to the 
cells and incubated for 30 minutes on ice. Primary antibody was omitted for negative control and wells were 
allocated for IgG/IgM positive controls. Cells were then washed in stain buffer, resuspended in 100µl of 
secondary antibody (Alexa Fluor 647) solution before incubating on ice for 30 minutes in the dark. 
Subsequently, cells were washed and centrifuged before being resuspended in 150µl of BD Pharmingen Stain 
Buffer + EDTA. Samples were then analysed using the BD FACSCabilur (BD Biosciences). 15,000-20,000 
events were collected per well and results were analysed using the FlowJo software.  
 
Histology and Immunohistochemistry  
Human foetal eyes were fixed in 4% (w/v) PFA/PBS overnight at 4°C; retinal explants/wholemounts and PSC-
derived retinal differentiation samples were fixed for 30 minutes at 4°C. For embedding, samples were washed 
three times in PBS and equilibrated in 30% (w/v) sucrose/PBS solution for cryo-protection at RT; once sunk, 
samples were then orientated and placed into foil moulds containing optimal cutting temperature (OCT) 
compound, before freezing in methylbutane-dry ice slurry. Tissue sections were cut to 14-16µm thickness using 
the Leica CM1900 UV cryostat and collected on SuperfrostTM plus glass slides (VWR). For 
immunohistochemistry, retinal sections were washed in PBS for 13 minutes at 37°C to remove the OCT 
compound (step excluded for wholemount staining) and incubated in BS (10% (v/v) foetal bovine serum 
(FBS)/PBS (Gibo), 1% (w/v) bovine serum albumin/PBS) with 0.1% (v/v) Triton X-100 for 1 hour at RT. 
Sections were subsequently incubated with primary antibody for 1 hour at RT or overnight at 4°C. Primary 
antibodies used in this study include Recoverin, Millipore, Cat no. AB5585, 1:1000; CRX, Abnova, Cat no. 
H00001406-M02, 1:800; L/M-opsin, Millipore, Cat no. AB5405, 1:500; S-opsin, Millipore, Cat No. AB5407, 
1:500; Rxrg, Abcam, Cat no. AB15518, 1:300; Gnat2, Santa Cruz, Cat no. sc-390, 1:300; Ki67, Abcam, Cat no. 
AB15580, 1:300; Nr2e3, R&D Systems, Cat no. 2ZH7223H,  1:500; Rhodopsin; Upstate, Cat no. 06-770 
1:1000; Nrl, R&D Systems, Cat no. AF2945, 1:500, Cone arrestin, NovusBio, Cat no. NBP1-19629 1:100. 
Primary antibody was omitted for negative controls. Sections were washed three times in 1x PBS before 
applying the secondary antibody for 1 hour at RT (AlexaFluor 594 Goat anti-rabbit (Cat no. A11037), 
AlexaFluor 488 Donkey anti-mouse (Cat no. A-21202) , AlexFluor 594 Donkey anti-goat (Cat no A-11058).  
Invitrogen, 1:800). Sections were washed 3 times with PBS prior to DAPI incubation (1:3000 in PBS) at RT for 
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5 minutes, allowing for the visualisation of cell nuclei. Sections were washed again in PBS, before applying 
with Citifluor AF-1 mounting medium, 1.5 coverslips and clear nail polish to seal coverslip.  
 
Microscopy and image processing  
Z-28 projection images of retinal sections and wholemount immunostainings were acquired using the Zeiss 
LSM710 (Zen2009, Zeiss) confocal microscope. Z-28 projection and at least 2x2 tile scan images were acquired 
for of FAC-sorted cells to be counted. Brightfield and fluorescent images of foetal pR2.1:GFP+ retinal explants 
were captured using the Leica MZFLIII fluorescence stereomicroscope and the Leica DC500 camera. 
Fluorescent and brightfield images of stem cell-derived cones were acquired using the inverted Olympus IX71 
(Carl Zeiss, Jena, Germany) microscope with a Hamamatsu ORCA-ER digital camera (Hamamatsu Corp., 
Bridgewater, NJ). Images were processed using Zen2009 (Zeiss), ImageJ and Illustrator CS6 (Adobe). Cell 
counting was completed using ImageJ software. 
 
RNA isolation and quantitative real-time PCR 
Retinal tissue was processed with the mirVana RNA extraction kit (Ambion) according to manufacturer’s 
recommendation. For qRT PCR analysis, RNA samples were treated with DNaseI (Invitrogen) and cDNA was 
synthesised using SuperScript III Reverse Transcriptase (Invitrogen). cDNA samples were diluted to the same 
concentration (5ng) with DEPC-treated water. RT qPCR procedure was carried out in 96 well plates with a total 
reaction volume of 20µl per well (2µl of cDNA sample, 17µl of TaqMan Gene Expression Master Mix (Thermo 
Fisher) with DEPC-treated water and 1µl of TaqMan gene expression assays (Thermo Fisher). The following 
gene expression assays were used in this study for detecting transcripts of interest: RXRG (Hs00199455_m1), 
ONECUT1 (Hs00413554_m1), THRB2 (AJ20TM1), SALL3 (Hs00923915_m1), GNAT2 (Hs00292542_m1), 
ARR3 (Hs00182888_m1), OPN1SW (Hs00181790_m1), OPN1LW/MW (Hs00241039_m1), RCVRN 
(Hs00610056_m1), CRX (Hs00230899_m1). The assay used for OPN1LW/MW detects transcripts from all L 
and M-opsin genes. GADPH (Hs02758991_g1) was used as an internal control to normalise the expression of 
candidate genes and sample cDNA was replaced with DEPC-treated water for negative controls. qRT PCRs 
were performed on a 7500 Real-Time PCR System with the FAM settings according to manufacturer’s 
recommendation. The following PCR cycle was used for all experiments: Stage 1, 1x cycle, 50°C for 2 minutes; 
Stage 2, 1x cycle, 95°C for 10 minutes; Stage 3, 40x cycles, 95°C for 15 seconds, 60°C for 60 seconds. The 
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Applied Biosystems 7500 Real Time PCR System software (v2.0.2) was used to assess quality of sample output 
before exporting and performing data analysis in Microsoft Excel. 
Bulk mRNA sequencing and bioinformatics analysis 
RNA concentration and quality was assessed on the Agilent Bioanalyzer or Tapestation using a RNA 6000 Pico 
kit (Agilent Technologies). High quality RNA (RIN:6.70-10) was used for RNA seq. cDNA quality was 
assessed using Qubit dsDNA HS Assay kit and Qubit 2.0 Fluorometer (ThermoFisher). pR2.1.GFP+ and GFP- 
FAC-sorted samples for bulk RNA-seq analysis were amplified using the SMART-Seq v4 Ultra Low Input 
RNA kit (Clontech Laboratories) and cDNA libraries were prepared using the Nextera XT DNA Library 
Preparation Kit (Illumina), before sequencing libraries using the Illumina NextSeq500 system with a targeted 
sequencing depth of 17million 43bp paired end per sample. FASTQ files containing raw RNA seq data were 
aligned using Illumina RNA Seq STAR alignment tool (version 1.1.0) to the reference human genome 
(GRCh37/hg19), in order to generate BAM files. Quality control was performed pre and post alignment using 
the RNA-Seq alignment tool in BaseSpace (Illumina). BAM files and a gene annotation file 
(Homo_sapiens.GRCh37.87.chr.gtf from Ensembl) were uploaded to Galaxy (version 17.01). Aligned reads 
were assigned to genes and quantified using featureCounts (version 1.4.6.p5 (Liao et al., 2014) to obtain a raw 
count matrix for each sample. The raw count matrices were loaded into Strand NGS (Strand Genomics), before 
performing DESeq normalisation for hierarchical clustering analysis (Euclidean similarity measure and Ward’s 
linkage rule used), and data visualisation using Principal Component Analysis (PCA) and making heatmap 
representations. The raw count matrices were then used as input to the DESeq2 (Love et al., 2014) pipeline 
using default parameters with the Galaxy version 2.11.38 for the differential gene expression analyses, which 
uses Wald test statistics and Benjamini-Hochberg correction for multiple testing. log10 adjusted p-values and 
log2 fold changes generated by these analyses were plotted using R (version 3.2.1 (2015-06-18) to create 
volcano plots. Genes with total raw count matrices lower than 10 across all samples were removed from 
analysis. Venn diagrams were constructed using Bioinformatic & Evolutionary Genomics tool 
(http://bioinformatics.psb.ugent.be/webtools/Venn/). GO analysis was performed using Enrichr (Chen et al., 
2013, Kuleshov et al., 2016) and enriched GO terms with a combined score >10 were represented using Revigo 
(Supek et al., 2011). Accession numbers E-MTAB-6057 can be used to access fastq files of all bulk RNA seq 
samples on ArrayExpress EMBL-EBI. 
 
Single cell RNA sequencing and bioinformatics analysis 
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For single cell analysis, pR2.1.GFP+ were isolated via FACS and separated using a medium-sized (10-17µm 
cell diameter) integrated fluidic circuit (IFC; Fluidigm), using the Fluidigm C1 system. Prior to loading on the 
IFC, cell viability was assessed using a standard trypan blue exclusion test before resuspending cells at a 
concentration of 667cells/µl. 3µl total sample volume was loaded onto IFC and cell were imaged via phase-
contrast microscopy to check for the single cell status of each chamber. 74 single cells were captured for the 
experiment and chambers containing debris, dead cells and multiple cells were excluded from the analysis. After 
collecting cell harvest from the IFC, amplification, cDNA libraries and sequencing was performed using the 
same bulk RNA seq procedures. A targeted sequencing depth of 2 million 75bp paired end reads per sample was 
used and External RNA Control Consortium (ERCC) RNA spike-in Mix (ThermoFisher) was added to each cell 
sample prior to sequencing. After the sequencing, FASTQ files from individual cell samples were aligned to the 
hg19 build of the human genome with ERCC spike-in sequences (Thermofisher) using subread version 1.5.0-p1 
(Liao et al 2013). The featureCounts software (Liao et al 2014) was used to obtain a matrix of gene by cell 
counts using gene feature files from Ensembl GRCh37 version 82 and ThermoFisher. The count matrix was 
then analyzed as described by (Lun et al., 2016b). Low quality cells were defined from several quality control 
metrics, including the log-library sizes and log-number of expressed features (where small outlier values were 
removed), and the proportion of reads mapped to the ERCC spike-ins or mitochondrial genome (where 
large outliers were removed). This led to the inclusion of 65 cells for the downstream analysis. Outlier values 
were defined as three median absolute deviations above or below the median. Low-abundance genes 
were defined as those with average counts below 1 and were filtered out, leaving 19,650 for downstream 
analysis. Normalization was performed for endogenous genes by computing size factors with the deconvolution 
method (Lun et al., 2016a). For spike-in transcripts, size factors were computed from the sum of spike-in counts 
in each cell. In both cases, the size factors were used to obtain normalized log-expression values for 
all genes/transcripts in all cells. To identify highly variable genes (HVGs), a trend was fitted to the variance of 
the log-expression values against the mean for the spike-ins. This was used to decompose the variance for 
endogenous genes into biological and technical components. HVGs were defined as those genes where the total 
variance was significantly higher than the technical trend (FDR<0.05) and the biological component was at 
least 0.5. The log-expression values for the HVGs across all cells were then used in a principal components 
analysis. Genes correlated with PC1 were identified using limma (Ritchie et al., 2015) as previously described. 
The observation that PC1 corresponds to cell maturation arose from unbiased analysis and was not fitted to 
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match some criteria. Accession numbers E-MTAB-6058 can be used to access fastq files single cell RNA seq 
samples on ArrayExpress EMBL-EBI. 
 
CD marker bioinformatics 
The cell surface marker protein query database contains predicted protein features based on human protein 
sequences from release 2013_04 of the UniProtKB/Swiss-Prot database, which can be used to identify putative 
cell surface markers within a list of genes. To create the database, proteins with sequence length > 1,500 amino 
acids were excluded as they were not compatible with some of the programs used for the feature predictions. A 
representative set of proteins with less than 90% pair-wise sequence identity was subsequently identified using 
the CD-HIT program (Li and Godzik, 2006). This resulted in a set of 19281 proteins, for which predictions were 
obtained using the following programs: MEMSAT-SVM (transmembrane segment prediction (Nugent and 
Jones, 2009), PredGPI (GPI anchor prediction, (Pierleoni et al., 2008), the specific Support Vector Machine 
trained for GO term GO:0005886 ‘plasma membrane’ within FFPred2 (version 2.0, (Minneci et al., 2013), and 
DISOPRED2 (protein disorder prediction,(Ward et al., 2004). The predictions were used to label all proteins in 
the database as either “positive” when it was predicted to be a putative cell surface marker, or “negative” 
otherwise. Criteria for assigning a putative cell surface marker required two criteria: i) at least 16 
transmembrane helices predicted by MEMSAT-SVM or a PredGPI prediction of “Highly Probable”, and ii) a 
“plasma membrane” FFPred2 prediction with confidence ≥ 0.8.  Applying these rules to the 19281 proteins 
present in the database, 3367 were labelled as “positive” and 15914 as “negative”. A benchmarking test was 
performed against a list of UniProt Identifiers for 206 known human cluster of differentiation cell surface (CD) 
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